Literature DB >> 17887931

Thyroid disease in patients with idiopathic thrombocytopenia: a cohort study.

Adriana G Ioachimescu1, Antoine Makdissi, Alan Lichtin, Robert S Zimmerman.   

Abstract

OBJECTIVES: To estimate the prevalence of the association between thyroid disease and idiopathic thrombocytopenia (ITP), and to examine the effect of treatment of the thyroid condition on platelet count.
DESIGN: Retrospective cohort study performed in a tertiary care center setting. All patients who were diagnosed with ITP by a single provider at the Cleveland Clinic Hematology/Oncology Department between 1988 and 2005 were included. MAIN OUTCOME: Among the 98 patients, thyroid function tests were available in 80 patients. Of these, 16 (20%) had abnormal thyroid function: 6 had hyperthyroidism and 10 had hypothyroidism. The median interval from the onset of the thyroid or hematological condition (whichever came first) was 84 months (range: 25-612). The autoimmune nature of the thyroid disease was proven in 12 cases (75%). Three patients showed a transient increase in the platelet count after restoring the euthyroid state; however, durable improvement of thrombocytopenia was not encountered.
CONCLUSIONS: The prevalence of hypothyroidism in patients with ITP is higher than in the general population. Based on this observation, routine assessment of thyroid function should be done in patients with ITP. The long-term course of ITP was not influenced by the treatment of the thyroid condition.

Entities:  

Mesh:

Year:  2007        PMID: 17887931     DOI: 10.1089/thy.2007.0066

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

Review 1.  The ITP syndrome: pathogenic and clinical diversity.

Authors:  Douglas B Cines; James B Bussel; Howard A Liebman; Eline T Luning Prak
Journal:  Blood       Date:  2009-04-24       Impact factor: 22.113

2.  Clinical association between thyroid disease and immune thrombocytopenia.

Authors:  Shoko Ito; Shin-Ichiro Fujiwara; Rui Murahashi; Hirotomo Nakashima; Sae Matsuoka; Takashi Ikeda; Shin-Ichiro Kawaguchi; Yumiko Toda; Tetsuaki Ban; Takashi Nagayama; Kento Umino; Daisuke Minakata; Kaoru Morita; Hirofumi Nakano; Ryoko Yamasaki; Masahiro Ashizawa; Chihiro Yamamoto; Kaoru Hatano; Kazuya Sato; Iekuni Oh; Ken Ohmine; Yoshinobu Kanda
Journal:  Ann Hematol       Date:  2020-11-09       Impact factor: 3.673

3.  Thyroid Dysfunction in Patients With Immune Thrombocytopenia: Prevalence and it's Impact On Outcome.

Authors:  Mukul Aggarwal; Manoranjan Mahapatra; Tulika Seth; Seema Tyagi; Nikhil Tandon; Renu Saxena
Journal:  Indian J Hematol Blood Transfus       Date:  2021-07-01       Impact factor: 0.900

4.  Relationship Between Thyroid Hormone Levels and Mean Platelet Count and Volume: Quantitative Assessment.

Authors:  Sardar H Ijaz; Shakeel M Jamal; Rehan Qayyum
Journal:  Cureus       Date:  2018-10-08

Review 5.  Understanding Immune Thrombocytopenia: Looking Out of the Box.

Authors:  Alexandra Schifferli; Franco Cavalli; Bertrand Godeau; Howard A Liebman; Mike Recher; Paul Imbach; Thomas Kühne
Journal:  Front Med (Lausanne)       Date:  2021-06-24

Review 6.  Pathobiology of secondary immune thrombocytopenia.

Authors:  Douglas B Cines; Howard Liebman; Roberto Stasi
Journal:  Semin Hematol       Date:  2009-01       Impact factor: 3.851

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.